Provided by Tiger Trade Technology Pte. Ltd.

JW THERAP-B

2.235
-0.015-0.67%
Volume:3.05M
Turnover:7.14M
Market Cap:932.00M
PE:-1.43
High:2.455
Open:2.255
Low:2.180
Close:2.250
52wk High:5.650
52wk Low:1.400
Shares:417.00M
HK Float Shares:417.00M
Volume Ratio:2.50
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.561
ROE:-49.74%
ROA:-1.17%
PB:1.77
PE(LYR):-1.43
PS:2.77

Loading ...

Sweden's Elicera Therapeutics Q2 Loss Widens

Reuters
·
Aug 28

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

JW (Cayman) Therapeutics H1 Net Income Attributable RMB -50.4 Million

THOMSON REUTERS
·
Aug 27

JW (Cayman) Therapeutics - no Dividend Paid or Proposed During Hy

THOMSON REUTERS
·
Aug 27

JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million

Reuters
·
Aug 27

JW Therapeutics to Review 2026 Interim Results on 27 August

Bulletin Express
·
Aug 12

JW Cayman Therapeutics Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 12

JW Therapeutics: No Share Capital Changes in July; 22.77 Million Options Outstanding

Bulletin Express
·
Aug 05

JW Therapeutics: June 2026 Return Shows Stable 416.73 Million Share Base and Sufficient Public Float

Bulletin Express
·
Jul 06

JW Cayman Therapeutics Files Directors List with Hong Kong Exchange

Reuters
·
Jun 26

JW THERAP-B Appoints Tian Feng as Chairman

Stock News
·
Jun 26

JW Cayman Therapeutics Names CEO Feng Tian Chairman After Cheng Liu Retires from Board

Reuters
·
Jun 26

JW Therapeutics Keeps Share Count Unchanged in May 2026; 23.07 Million Options Remain Outstanding

Bulletin Express
·
Jun 03

Market Chatter: 'Business as Usual' for China Drugmakers Despite Scrutiny of Cross-Border Tech Deals, JW Therapeutics CEO Says

MT Newswires Live
·
May 27

JW THERAP-B Sets 26 June 2026 AGM to Vote on FY2025 Results, Director Slate, Auditor Re-appointment and Share Mandates

Bulletin Express
·
May 26

JW Therapeutics Grants 2.00 Million Share Options to CEO Feng Tian at HK$2.32 Exercise Price

Bulletin Express
·
May 19

JW THERAP-B (02126) Grants 2 Million Share Options

Stock News
·
May 19

JW THERAP-B Issues 0.26 Million New Shares in April; Outstanding Options Rise to 21.07 Million

Bulletin Express
·
May 07

JW THERAP-B 2025 ESG Report: Governance Strength, Drug Innovation and Carbon-Cut Wins Spotlight

Bulletin Express
·
Apr 28

JW THERAP-B:2025年营收达2.837亿元,同比增长79.3%,核心产品销售与许可收入双驱动业绩提升

Bulletin Express
·
Apr 28